LifeMD® Launches TestoRx, a New Rex MD® Direct-to-Consumer Testosterone Replacement Therapy Telehealth Offering

Stock Information for Augmedix Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Augmedix Inc.

LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution
LifeMD to Participate in Three Investor Conferences During November
LifeMD Reports Third Quarter 2024 Results
LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency
LifeMD® to Report Third Quarter 2024 Financial Results on November 7
LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options
LifeMD to Participate in Three Investor Conferences During September

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.